89 related articles for article (PubMed ID: 25665619)
41. The role of complement in the antiphospholipid syndrome: a novel mechanism for pregnancy morbidity.
Samarkos M; Mylona E; Kapsimali V
Semin Arthritis Rheum; 2012 Aug; 42(1):66-9. PubMed ID: 22405029
[TBL] [Abstract][Full Text] [Related]
42. C5A anaphylatoxin and its seven transmembrane-segment receptor.
Gerard C; Gerard NP
Annu Rev Immunol; 1994; 12():775-808. PubMed ID: 8011297
[TBL] [Abstract][Full Text] [Related]
43. [The Immunosuppressive Function of Myeloid-derived Suppressor Cells Is Regulated by the HMGB1-TLR4 Axis].
Tachibana M
Yakugaku Zasshi; 2018; 138(2):143-148. PubMed ID: 29386427
[TBL] [Abstract][Full Text] [Related]
44. Brief report: complement C5a promotes human embryonic stem cell pluripotency in the absence of FGF2.
Hawksworth OA; Coulthard LG; Taylor SM; Wolvetang EJ; Woodruff TM
Stem Cells; 2014 Dec; 32(12):3278-84. PubMed ID: 25132103
[TBL] [Abstract][Full Text] [Related]
45. Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke.
Floreani AA; Heires AJ; Welniak LA; Miller-Lindholm A; Clark-Pierce L; Rennard SI; Morgan EL; Sanderson SD
J Immunol; 1998 May; 160(10):5073-81. PubMed ID: 9590258
[TBL] [Abstract][Full Text] [Related]
46. Complement activation during sepsis in humans.
Schreiber H; Rittirsch D; Flierl M; Brueckner U; Schneider M; Weiss M; Gebhard F; Huber-Lang M
Adv Exp Med Biol; 2006; 586():217-26. PubMed ID: 16893075
[No Abstract] [Full Text] [Related]
47. Neutrophil C5a receptor and the outcome in a rat model of sepsis.
Guo RF; Riedemann NC; Bernacki KD; Sarma VJ; Laudes IJ; Reuben JS; Younkin EM; Neff TA; Paulauskis JD; Zetoune FS; Ward PA
FASEB J; 2003 Oct; 17(13):1889-91. PubMed ID: 12897064
[TBL] [Abstract][Full Text] [Related]
48. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.
Cortright DN; Meade R; Waters SM; Chenard BL; Krause JE
Curr Eye Res; 2009 Jan; 34(1):57-61. PubMed ID: 19172471
[TBL] [Abstract][Full Text] [Related]
49. Signaling through C5aR is not involved in basal neurogenesis.
Bogestål YR; Barnum SR; Smith PL; Mattisson V; Pekny M; Pekna M
J Neurosci Res; 2007 Oct; 85(13):2892-7. PubMed ID: 17551982
[TBL] [Abstract][Full Text] [Related]
50. Taming TLR4 may ease seizures.
Kleen JK; Holmes GL
Nat Med; 2010 Apr; 16(4):369-70. PubMed ID: 20376038
[No Abstract] [Full Text] [Related]
51. Getting over our Immune-Complex - C5a receptor blockade is the answer.
Thurman JM
Cell Mol Immunol; 2017 Mar; 14(3):319-320. PubMed ID: 26144251
[No Abstract] [Full Text] [Related]
52. Peroxiredoxin sets the brain on fire after stroke.
Garcia-Bonilla L; Iadecola C
Nat Med; 2012 Jun; 18(6):858-9. PubMed ID: 22673994
[TBL] [Abstract][Full Text] [Related]
53. Coronary vein grafting: the flags keep waving but the game goes on.
Newby AC
Cardiovasc Res; 2013 Feb; 97(2):193-4. PubMed ID: 23188695
[No Abstract] [Full Text] [Related]
54. Invited commentary.
Jones JA
Ann Thorac Surg; 2015 Jan; 99(1):71. PubMed ID: 25555935
[No Abstract] [Full Text] [Related]
55. [Advances in research of the roles of C5a-C5L2, high mobility group B1 and Toll like receptor 4 in sepsis].
Fang Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):155-7. PubMed ID: 25665619
[No Abstract] [Full Text] [Related]
56. Novel complementary peptides to target molecules.
Okada H; Imai M; Ono F; Okada A; Tada T; Mizue Y; Terao K; Okada N
Anticancer Res; 2011 Jul; 31(7):2511-6. PubMed ID: 21873168
[TBL] [Abstract][Full Text] [Related]
57. Evidence for a functional role of the second C5a receptor C5L2.
Gao H; Neff TA; Guo RF; Speyer CL; Sarma JV; Tomlins S; Man Y; Riedemann NC; Hoesel LM; Younkin E; Zetoune FS; Ward PA
FASEB J; 2005 Jun; 19(8):1003-5. PubMed ID: 15784721
[TBL] [Abstract][Full Text] [Related]
58. A key role of C5a/C5aR activation for the development of sepsis.
Riedemann NC; Guo RF; Ward PA
J Leukoc Biol; 2003 Dec; 74(6):966-70. PubMed ID: 12960283
[TBL] [Abstract][Full Text] [Related]
59. The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome.
Flierl MA; Schreiber H; Huber-Lang MS
J Invest Surg; 2006; 19(4):255-65. PubMed ID: 16835140
[TBL] [Abstract][Full Text] [Related]
60. The enigma of sepsis.
Riedemann NC; Guo RF; Ward PA
J Clin Invest; 2003 Aug; 112(4):460-7. PubMed ID: 12925683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
